Alyeska Investment Group, L.P. Edwards Lifesciences Corp Transaction History

Alyeska Investment Group, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$67.19 - $87.44 $5.03 Million - $6.54 Million	-74,822 Reduced 83.08%	15,236 $1.22 Million
Q1 2020 May 15, 2020	SELL	$52.41 - $81.0 $5.12 Million - $7.91 Million	-97,611 Reduced 52.01%	90,058 $5.66 Million
Q1 2018 May 15, 2018	BUY	$37.19 - $47.45 $6.98 Million - $8.9 Million	187,669 New	187,669 $26.2 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.